INNOSENSE CORPORATION — Department of Defense STTR Phase I: DHA19A-001
INNOSENSE CORPORATION — STTR Phase I award from Department of Defense.
- Amount
- $162,499
- Agency
- Department of Defense · Defense Health Program
- Program / Phase
- STTR · Phase I
- Topic
- DHA19A-001
- Solicitation
- 19.A
- NAICS
- —
- Place of performance
- CA
- Period
- 2019-07-24 → 2020-02-24
Description
Defense Health Agency (DHA) is seeking a multi-functional diagnostic to determine blood coagulopathy in real time at point-of-care (POC). Blood coagulopathy, resulting in uncontrolled bleeding, is implicated in 80% of operating room deaths and 50% of trau